Résultats de la recherche - Takao Koike
- Résultat(s) 1 - 20 résultats de 46
- Aller à la page suivante
-
1
-
2
-
3
-
4
Immunological Evidence that Non-carboxymethyllysine Advanced Glycation End-products Are Produced from Short Chain Sugars and Dicarbonyl Compounds in vivo par Masayoshi Takeuchi, Zenji Makita, Richard Bucala, Takako Suzuki, Takao Koike, Yukihiko Kameda
Publié 2000Artigo -
5
Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled... par Nobuyuki Miyasaka, Masako Hara, Takao Koike, Eizo Saito, Masahito Yamada, Yoshiya Tanaka
Publié 2011Artigo -
6
Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled... par Nobuyuki Miyasaka, Masako Hara, Takao Koike, Eizo Saito, Masahito Yamada, Yoshiya Tanaka
Publié 2012Artigo -
7
-
8
-
9
High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low dr... par Tsutomu Takeuchi, Nobuyuki Miyasaka, Takashi Inui, Toshiro Yano, Toru Yoshinari, Tohru Abe, Takao Koike
Publié 2017Artigo -
10
Progression of Nephropathy in Spontaneous Diabetic Rats Is Prevented by OPB-9195, a Novel Inhibitor of Advanced Glycation par Sakurako Nakamura, Zenji Makita, Shintaro Ishikawa, KOICHI YASUMURA, Wataru Fujii, Katsuyuki Yanagisawa, Tetsuya Kawata, Takao Koike
Publié 1997Artigo -
11
-
12
-
13
-
14
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients par Takao Koike, Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Shuji Takei, Tsutomu Takeuchi, Hisashi Yamanaka, Yoshiya Tanaka
Publié 2012Artigo -
15
Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases par Masaru Kato, Tatsuya Atsumi, Takashi Kurita, Toshio Odani, Yuichiro Fujieda, Kotaro Otomo, Tetsuya Horita, Shinsuke Yasuda, Takao Koike
Publié 2011Artigo -
16
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy par Yoshiya Tanaka, Tsutomu Takeuchi, Nobuyuki Miyasaka, Takayuki Sumida, Tsuneyo Mimori, Takao Koike, Kazuhiro Endo, Naomi Mashino, Kazuhiko Yamamoto
Publié 2015Artigo -
17
Phosphorylation of the 6-Phosphofructo-2-Kinase/Fructose 2,6-Bisphosphatase/PFKFB3 Family of Glycolytic Regulators in Human Cancer par Hidenori Bando, Toshiya Atsumi, Taro Nishio, Hirokatsu Niwa, Shinya Mishima, Chikara Shimizu, Narihito Yoshioka, Richard Bucala, Takao Koike
Publié 2005Artigo -
18
Expression of Inducible 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase/PFKFB3 Isoforms in Adipocytes and Their Potential Role in Glycolytic Regulation par Toshiya Atsumi, Taro Nishio, Hirokatsu Niwa, Jun Takeuchi, Hidenori Bando, Chikara Shimizu, Narihito Yoshioka, Richard Bucala, Takao Koike
Publié 2005Artigo -
19
Defective Expression of Ras Guanyl Nucleotide-Releasing Protein 1 in a Subset of Patients with Systemic Lupus Erythematosus par Shinsuke Yasuda, Richard L Stevens, Tomoko Terada, Masumi Takeda, Toko Hashimoto, Jun Fukae, Tetsuya Horita, Hiroshi Kataoka, Tatsuya Atsumi, Takao Koike
Publié 2007Artigo -
20
A multicenter phase I/II trial of rituximab for refractory systemic lupus erythematosus par Yoshiya Tanaka, Kazuhiko Yamamoto, Tsutomu Takeuchi, Norihiro Nishimoto, Nobuyuki Miyasaka, Takayuki Sumida, Yoshihito Shima, Kazuki Takada, Isao Matsumoto, Kazuyoshi Saito, Takao Koike
Publié 2007Artigo
Outils de recherche:
Sujets similaires
Medicine
Internal medicine
Immunology
Biology
Rheumatoid arthritis
Adverse effect
Antibody
Rheumatology
Endocrinology
Pathology
Arthritis
Biochemistry
Gastroenterology
Methotrexate
Randomized controlled trial
Alternative medicine
Chemistry
Gene
Placebo
Adalimumab
Diabetes mellitus
Disease
Etanercept
Genetics
Postmarketing surveillance
Tumor necrosis factor alpha
Glycation
Infliximab
Molecular biology
Physics